Published in Antimicrob Agents Chemother on September 01, 1989
Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones. J Bacteriol (1990) 7.61
Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae. Antimicrob Agents Chemother (1996) 7.10
Molecular properties of bacterial multidrug transporters. Microbiol Mol Biol Rev (2000) 5.21
DNA gyrase gyrA mutations in ciprofloxacin-resistant strains of Staphylococcus aureus: close similarity with quinolone resistance mutations in Escherichia coli. J Bacteriol (1990) 5.13
A novel locus conferring fluoroquinolone resistance in Staphylococcus aureus. J Bacteriol (1991) 3.70
DNA cloning and organization of the Staphylococcus aureus gyrA and gyrB genes: close homology among gyrase proteins and implications for 4-quinolone action and resistance. J Bacteriol (1990) 2.96
Ciprofloxacin-resistant methicillin-resistant Staphylococcus aureus in an acute-care hospital. Antimicrob Agents Chemother (1990) 2.91
Plasmid-mediated 4-quinolone resistance: a real or apparent absence? Antimicrob Agents Chemother (1990) 1.75
Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance. Clin Microbiol Rev (2012) 1.74
Multidrug resistance in Staphylococcus aureus due to overexpression of a novel multidrug and toxin extrusion (MATE) transport protein. Antimicrob Agents Chemother (2005) 1.66
Mechanisms of clinical resistance to fluoroquinolones in Staphylococcus aureus. Antimicrob Agents Chemother (1991) 1.51
Efflux-related resistance to norfloxacin, dyes, and biocides in bloodstream isolates of Staphylococcus aureus. Antimicrob Agents Chemother (2007) 1.48
Hydrophilicity of quinolones is not an exclusive factor for decreased activity in efflux-mediated resistant mutants of Staphylococcus aureus. Antimicrob Agents Chemother (1996) 1.42
Mechanisms of resistance to quinolones. Drugs (1993) 1.41
Antibacterial activity of gatifloxacin (AM-1155, CG5501, BMS-206584), a newly developed fluoroquinolone, against sequentially acquired quinolone-resistant mutants and the norA transformant of Staphylococcus aureus. Antimicrob Agents Chemother (1998) 1.31
Quinolone susceptibility of norA-disrupted Staphylococcus aureus. Antimicrob Agents Chemother (1997) 1.24
Emergence of quinolone resistance among clinical isolates of methicillin-resistant Staphylococcus aureus in Ontario, Canada. Antimicrob Agents Chemother (1991) 1.22
Differing activities of quinolones against ciprofloxacin-susceptible and ciprofloxacin-resistant, methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1991) 1.21
Staphylococcus aureus HrtA is an ATPase required for protection against heme toxicity and prevention of a transcriptional heme stress response. J Bacteriol (2008) 1.13
Mechanisms of quinolone resistance. Infection (1994) 1.13
Ciprofloxacin-induced, low-level resistance to structurally unrelated antibiotics in Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1993) 1.06
Mechanisms of drug resistance: quinolone resistance. Ann N Y Acad Sci (2015) 1.00
Cloning of multidrug resistance gene pqrA from Proteus vulgaris. Antimicrob Agents Chemother (1995) 0.99
Comparative in vitro activities of a new quinolone, OPC-17116, possessing potent activity against gram-positive bacteria. Antimicrob Agents Chemother (1992) 0.97
Contribution of CmeG to antibiotic and oxidative stress resistance in Campylobacter jejuni. J Antimicrob Chemother (2010) 0.97
Multidrug efflux pumps from Enterobacteriaceae, Vibrio cholerae and Staphylococcus aureus bacterial food pathogens. Int J Environ Res Public Health (2015) 0.96
Multidrug Efflux Pumps in Staphylococcus aureus: an Update. Open Microbiol J (2013) 0.95
DX-619, a novel des-fluoro(6) quinolone manifesting low frequency of selection of resistant Staphylococcus aureus mutants: quinolone resistance beyond modification of type II topoisomerases. Antimicrob Agents Chemother (2005) 0.91
Biochemistry of bacterial multidrug efflux pumps. Int J Mol Sci (2012) 0.88
Fluoroquinolone efflux in Streptococcus suis is mediated by SatAB and not by SmrA. Antimicrob Agents Chemother (2011) 0.83
Modulation of Bacterial Multidrug Resistance Efflux Pumps of the Major Facilitator Superfamily. Int J Bacteriol (2015) 0.83
NorA plasmid resistance to fluoroquinolones: role of copy number and norA frameshift mutations. Antimicrob Agents Chemother (1996) 0.81
Bacterial Multidrug Efflux Pumps: Much More Than Antibiotic Resistance Determinants. Microorganisms (2016) 0.79
Accumulation of norfloxacin by Mycobacterium aurum and Mycobacterium smegmatis. Antimicrob Agents Chemother (1998) 0.78
Preface: the concept and consequences of multidrug resistance. Pflugers Arch (2006) 0.77
Lack of effect of carbonyl cyanide m-chlorophenylhydrazone on KB-5246 accumulation by Staphylococcus aureus. Antimicrob Agents Chemother (1992) 0.75
Multidrug Intrinsic Resistance Factors in Staphylococcus aureus Identified by Profiling Fitness within High-Diversity Transposon Libraries. MBio (2016) 0.75
Binding of the Lactococcal Drug Dependent Transcriptional Regulator LmrR to Its Ligands and Responsive Promoter Regions. PLoS One (2015) 0.75
Calcium-dependent bacteriophage DNA infection. J Mol Biol (1970) 53.43
In vitro antibacterial activity of AM-715, a new nalidixic acid analog. Antimicrob Agents Chemother (1980) 26.28
In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents. Antimicrob Agents Chemother (1983) 21.48
In vitro and in vivo activity of DL-8280, a new oxazine derivative. Antimicrob Agents Chemother (1982) 21.31
Nalidixic acid resistance: a second genetic character involved in DNA gyrase activity. Proc Natl Acad Sci U S A (1977) 18.37
DNA gyrase: an enzyme that introduces superhelical turns into DNA. Proc Natl Acad Sci U S A (1976) 17.42
High frequency transformation of Bacillus subtilis protoplasts by plasmid DNA. Mol Gen Genet (1979) 17.16
Mechanism of action of nalidixic acid: purification of Escherichia coli nalA gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme. Proc Natl Acad Sci U S A (1977) 14.75
Gel electrophoresis of restriction fragments. Methods Enzymol (1979) 9.01
Escherichia coli K-12 mutants resistant to nalidixic acid: genetic mapping and dominance studies. J Bacteriol (1969) 8.78
Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria. Antimicrob Agents Chemother (1984) 8.62
Molecular cloning of the gene of a penicillin-binding protein supposed to cause high resistance to beta-lactam antibiotics in Staphylococcus aureus. J Bacteriol (1986) 6.97
Quinolone-resistant mutations of the gyrA gene of Escherichia coli. Mol Gen Genet (1988) 6.30
Genetic and biochemical characterization of norfloxacin resistance in Escherichia coli. Antimicrob Agents Chemother (1986) 6.20
Occurrence of a beta-lactam-inducible penicillin-binding protein in methicillin-resistant staphylococci. Antimicrob Agents Chemother (1985) 6.19
Differences in susceptibility to quinolones of outer membrane mutants of Salmonella typhimurium and Escherichia coli. Antimicrob Agents Chemother (1986) 6.03
Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12. Antimicrob Agents Chemother (1986) 6.00
Nalidixic acid-resistant mutations of the gyrB gene of Escherichia coli. Mol Gen Genet (1986) 5.95
DNA gyrase: subunit structure and ATPase activity of the purified enzyme. Proc Natl Acad Sci U S A (1978) 5.60
Purification of subunits of Escherichia coli DNA gyrase and reconstitution of enzymatic activity. Proc Natl Acad Sci U S A (1978) 5.33
Mutations producing resistance to norfloxacin in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1987) 4.96
DNA gyrase: purification and catalytic properties of a fragment of gyrase B protein. Proc Natl Acad Sci U S A (1979) 4.34
Expression and inducibility in Staphylococcus aureus of the mecA gene, which encodes a methicillin-resistant S. aureus-specific penicillin-binding protein. J Bacteriol (1989) 4.22
Purification and properties of DNA gyrase from a fluoroquinolone-resistant strain of Escherichia coli. Antimicrob Agents Chemother (1986) 3.69
In vitro and in vivo antibacterial activities of T-3262, a new fluoroquinolone. Antimicrob Agents Chemother (1988) 3.52
Cloning and simplified purification of Escherichia coli DNA gyrase A and B proteins. J Biol Chem (1984) 2.98
Activity of ciprofloxacin against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1985) 2.58
Norfloxacin resistance in a clinical isolate of Escherichia coli. Antimicrob Agents Chemother (1987) 2.33
Nucleotide sequence of the pbpA gene and characteristics of the deduced amino acid sequence of penicillin-binding protein 2 of Escherichia coli K12. Eur J Biochem (1986) 1.98
Mutation affecting resistance of Escherichia coli K12 to nalidixic acid. J Gen Microbiol (1985) 1.89
Genetic and physical organization of the cloned gyrA and gyrB genes of Bacillus subtilis. J Bacteriol (1985) 1.77
Clinical isolate of Citrobacter freundii highly resistant to new quinolones. Antimicrob Agents Chemother (1988) 1.19
[Trends of fluoroquinolone-resistant strains isolated from clinical materials]. Kansenshogaku Zasshi (1988) 0.86
Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones. J Bacteriol (1990) 7.61
Molecular cloning of the gene of a penicillin-binding protein supposed to cause high resistance to beta-lactam antibiotics in Staphylococcus aureus. J Bacteriol (1986) 6.97
Occurrence of a beta-lactam-inducible penicillin-binding protein in methicillin-resistant staphylococci. Antimicrob Agents Chemother (1985) 6.19
Expression and inducibility in Staphylococcus aureus of the mecA gene, which encodes a methicillin-resistant S. aureus-specific penicillin-binding protein. J Bacteriol (1989) 4.22
Enzyme structure with two catalytic sites for double-sieve selection of substrate. Science (1998) 3.92
Homology of mecA gene in methicillin-resistant Staphylococcus haemolyticus and Staphylococcus simulans to that of Staphylococcus aureus. Antimicrob Agents Chemother (1990) 3.09
Association of amino acid substitutions in penicillin-binding protein 3 with beta-lactam resistance in beta-lactamase-negative ampicillin-resistant Haemophilus influenzae. Antimicrob Agents Chemother (2001) 2.46
Rapid detection of the mecA gene in methicillin-resistant staphylococci by enzymatic detection of polymerase chain reaction products. J Clin Microbiol (1992) 2.42
Reproducible establishment of hemopoietic supportive stromal cell lines from murine bone marrow. Exp Hematol (1989) 2.31
Crystal structure of the E166A mutant of extended-spectrum beta-lactamase Toho-1 at 1.8 A resolution. J Mol Biol (1999) 2.14
In vitro activity of LJC10,627, a new carbapenem antibiotic with high stability to dehydropeptidase I. Antimicrob Agents Chemother (1990) 2.05
Purification and characterization of aminoglycoside-modifying enzymes from Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob Agents Chemother (1984) 1.67
Crystal structure of Escherichia coli methionyl-tRNA synthetase highlights species-specific features. J Mol Biol (1999) 1.57
Restriction maps of the regions coding for methicillin and tobramycin resistances on chromosomal DNA in methicillin-resistant staphylococci. Antimicrob Agents Chemother (1989) 1.53
Combinational detection of autolysin and penicillin-binding protein 2B genes of Streptococcus pneumoniae by PCR. J Clin Microbiol (1996) 1.49
Chromatographic assay of mixed penicillins, ampicillin and cloxacillin in body fluids. J Antibiot (Tokyo) (1970) 1.48
The 2.0 A crystal structure of Thermus thermophilus methionyl-tRNA synthetase reveals two RNA-binding modules. Structure (2000) 1.40
Incipient space weathering observed on the surface of Itokawa dust particles. Science (2011) 1.35
The crystal structure of muscle phosphoglucomutase refined at 2.7-angstrom resolution. J Biol Chem (1992) 1.23
The structure of rabbit muscle phosphoglucomutase at intermediate resolution. J Biol Chem (1986) 1.19
New plasmid (pTU512), mediating resistance to penicillin, erythromycin, and kanamycin, from clinical isolates of Staphylococcus aureus. Antimicrob Agents Chemother (1978) 1.17
Measurement of direct photon production in p+p collisions at sqrt[s] = 200 GeV. Phys Rev Lett (2007) 1.16
Transduction of drug resistance to tetracycline, chloramphenicol, macrolides, lincomycin and clindamycin with phages induced from Streptococcus pyogenes. J Antibiot (Tokyo) (1975) 1.09
Bedside evaluation of right ventricular performance using a rapid computerized thermodilution method. Crit Care Med (1987) 1.06
Directly repeated insertion of 9-nucleotide sequence detected in penicillin-binding protein 2B gene of penicillin-resistant Streptococcus pneumoniae. Antimicrob Agents Chemother (1996) 1.05
Upshaw-Schulman syndrome revisited: a concept of congenital thrombotic thrombocytopenic purpura. Int J Hematol (2001) 1.05
Crystallographic and mutational analyses of an extremely acidophilic and acid-stable xylanase: biased distribution of acidic residues and importance of Asp37 for catalysis at low pH. Protein Eng (1998) 1.04
Atomic imaging using secondary electrons in a scanning transmission electron microscope: experimental observations and possible mechanisms. Ultramicroscopy (2010) 0.96
Enhancement of the grafting efficiency of transplanted marrow cells by preincubation with interleukin-3 and granulocyte-macrophage colony-stimulating factor. Blood (1991) 0.93
The pH-dependent changes of the enzymic activity and spectroscopic properties of iron-substituted manganese superoxide dismutase. A study on the metal-specific activity of Mn-containing superoxide dismutase. Eur J Biochem (1995) 0.93
Disseminated Trichosporon capitatum infection in a patient with acute leukemia. Cancer (1988) 0.91
A possible association between hepatitis-B antigen-negative infantile papular acrodermatitis and Epstein-Barr virus infection. J Pediatr (1982) 0.88
Absence of suppression in particle production at large transverse momentum in sqrt[s(NN)]=200 GeV d+Au collisions. Phys Rev Lett (2003) 0.87
[Trends of fluoroquinolone-resistant strains isolated from clinical materials]. Kansenshogaku Zasshi (1988) 0.86
Evaluation of the time weighted average of air contaminants with special references to concentration fluctuation and biological half time. Am Ind Hyg Assoc J (1980) 0.85
[Relationship between resistant pattern to antibiotics and phage type of methicillin-resistant Staphylococcus aureus]. Kansenshogaku Zasshi (1985) 0.85
Transition in yield and azimuthal shape modification in dihadron correlations in relativistic heavy ion collisions. Phys Rev Lett (2010) 0.85
Plasma of patients with Upshaw-Schulman syndrome, a congenital deficiency of von Willebrand factor-cleaving protease activity, enhances the aggregation of normal platelets under high shear stress. Br J Haematol (2001) 0.85
Kawasaki disease and an unusual primary infection with Epstein-Barr virus. Pediatrics (1984) 0.85
New antagonists of leukotrienes: ONO-RS-411 and ONO-RS-347. Adv Prostaglandin Thromboxane Leukot Res (1985) 0.84
Regional cerebral blood flow abnormalities in late-life depression: relation to refractoriness and chronification. Psychiatry Clin Neurosci (1998) 0.82
Urine-based enzyme-linked immunosorbent assay for the detection of Helicobacter pylori infection in children. Pediatrics (2001) 0.82
Kawasaki disease and Epstein-Barr virus infection. Prog Clin Biol Res (1987) 0.82
Measurement of direct photons in Au+Au collisions at √(s(NN))=200 GeV. Phys Rev Lett (2012) 0.81
Prevalence and clinical characteristics of patients with atrial fibrillation: analysis of 20,000 cases in Japan. Jpn Circ J (2000) 0.81
Decreased serum apolipoprotein A-I concentrations in cows infected with Salmonella typhimurium. Can J Vet Res (1997) 0.81
[A case of scrub typhus with disseminated intravascular coagulation, meningitis and pulmonary fibrosis]. Nihon Naika Gakkai Zasshi (1991) 0.81
Detection of Epstein-Barr virus sequences in patients with Kawasaki disease by means of the polymerase chain reaction. Intervirology (1992) 0.80
[Three-dimensional computed tomography angiography of coronary artery bypass graft with electron beam tomography]. J Cardiol (2001) 0.80
[Morphological studies on antibacterial activities of cefotiam (author's transl)]. Jpn J Antibiot (1979) 0.80
Quadrupole anisotropy in dihadron azimuthal correlations in central d+Au collisions at √(s(NN))=200 GeV. Phys Rev Lett (2013) 0.80
Effects of prolonged nitrous oxide exposure on hemopoietic stem cells in splenectomized mice. Anesth Analg (1990) 0.80
System size and energy dependence of jet-induced hadron pair correlation shapes in Cu+Cu and Au+Au collisions at square root sNN=200 and 62.4 GeV. Phys Rev Lett (2007) 0.79
Management of severe neutropenia with cyclosporin during initial treatment of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis. Leuk Lymphoma (2000) 0.79
Potential of polar lipids from bovine milk to regulate the rodent dorsal hair cycle. J Dairy Sci (2012) 0.79
Medium modification of jet fragmentation in Au+Au collisions at √[s(NN)]=200 GeV measured in direct photon-hadron correlations. Phys Rev Lett (2013) 0.78
Synthesis and 5-lipoxygenase inhibitory activities of eicosanoid compounds. J Med Chem (1983) 0.78
New potent antagonists of leukotrienes C4 and D4. 1. Synthesis and structure-activity relationships. J Med Chem (1988) 0.78
Allelotype analysis of gallbladder carcinoma associated with anomalous junction of pancreaticobiliary duct. Cancer Lett (2001) 0.78
[Radioimmunoassay for plasma dihydrotestosterone (1)]. Nihon Naibunpi Gakkai Zasshi (1973) 0.78
Suppression pattern of neutral pions at high transverse momentum in Au + Au collisions at sqrt[sNN]=200 GeV and constraints on medium transport coefficients. Phys Rev Lett (2008) 0.77
Heterogeneity of myocardial wall motion and thickening in the left ventricle evaluated with quantitative gated SPECT. J Nucl Cardiol (2000) 0.77
[Serum adenosine deaminase and angiotensin converting enzyme activity in patients with endogenous uveitis]. Nippon Ganka Gakkai Zasshi (1994) 0.76
In vitro validation of a thermodilution right ventricular ejection fraction method. J Clin Monit (1992) 0.76
Glucose 6-phosphate dehydrogenase variants: a unique variant (G6PD Kobe) showed an extremely increased affinity for galactose 6-phosphate and a new variant (G6PD Sapporo) resembling G6PD Pea Ridge. Hum Genet (1981) 0.76
Measurement of high-pT single electrons from heavy-flavor decays in p + p collisions at square root of s = 200 GeV. Phys Rev Lett (2006) 0.76
Cross section and parity-violating spin asymmetries of W± boson production in polarized p + p collisions at sqrt[s] = 500 GeV. Phys Rev Lett (2011) 0.76
A new dynamic myocardial phantom for the assessment of left ventricular function by gated single-photon emission tomography. Eur J Nucl Med (2000) 0.75
Cold nuclear matter effects on J/ψ yields as a function of rapidity and nuclear geometry in d+A collisions at sqrt[s(NN)]=200 GeV. Phys Rev Lett (2011) 0.75
Enhanced production of direct photons in Au + Au collisions at square root(S(NN)) = 200 GeV and implications for the initial temperature. Phys Rev Lett (2010) 0.75
Nuclear modification of ψ', χc, and J/ψ production in d+Au collisions at sqrt[s(NN)]=200 GeV. Phys Rev Lett (2013) 0.75
Measurement of bottom versus charm as a function of transverse momentum with electron-hadron correlations in p + p collisions at square root of s = 200 GeV. Phys Rev Lett (2009) 0.75
J/psi production in sqrt s_NN=200 GeV Cu+Cu collisions. Phys Rev Lett (2008) 0.75
Comparison between segmental wall motion and wall thickening in patients with coronary artery disease using quantitative gated SPECT software. Int J Card Imaging (2000) 0.75
J/psi production versus transverse momentum and rapidity in p+p collisions at square root s=200 GeV. Phys Rev Lett (2007) 0.75
Scaling properties of azimuthal anisotropy in Au+Au and Cu+Cu Collisions at sqrt[s NN]=200 GeV. Phys Rev Lett (2007) 0.75
In situ high resolution electron microscopy/electron energy loss spectroscopy observation of wetting of a Si surface by molten Al. J Microsc (2001) 0.75
Source breakup dynamics in Au + Au collisions at sqrt[s(NN)]=200 GeV via three-dimensional two-pion source imaging. Phys Rev Lett (2008) 0.75
Suppression of back-to-back hadron pairs at forward rapidity in d+Au collisions at √s(NN)=200 GeV. Phys Rev Lett (2011) 0.75
[Community-acquired infections caused by Streptococcus pneumoniae and Haemophilus influenzae(discussion)]. Jpn J Antibiot (2001) 0.75
Dynamic chemical mapping near a Si/SiO2 interface at elevated temperatures using plasmon-loss images. J Microsc (2001) 0.75
J/psi production versus centrality, transverse momentum, and rapidity in Au+Au collisions at square root sNN=200 GeV. Phys Rev Lett (2007) 0.75
Azimuthal anisotropy of π⁰ production in Au+Au collisions at sqrt((s)NN)=200 GeV: path-length dependence of jet quenching and the role of initial geometry. Phys Rev Lett (2010) 0.75
Gluon-spin contribution to the proton spin from the double-helicity asymmetry in inclusive pi0 production in polarized p+p collisions at [sqrt]s=200 GeV. Phys Rev Lett (2009) 0.75
Measurements of higher order flow harmonics in Au+Au collisions at √s(NN)=200 GeV. Phys Rev Lett (2011) 0.75
Elliptic flow for phi mesons and (anti)deuterons in Au+Au collisions at square root of sNN=200 GeV. Phys Rev Lett (2007) 0.75
A 13C-urea breath test in children with helicobacter pylori infection: assessment of eradication therapy and follow-up after treatment. J Gastroenterol (2001) 0.75
Double helicity asymmetry in inclusive midrapidity pi0 production for polarized p+p collisions at square root s = 200 GeV. Phys Rev Lett (2004) 0.75
Azimuthal angle correlations for rapidity separated Hadron pairs in d+Au collisions at square root of sNN=200 GeV. Phys Rev Lett (2006) 0.75
Nuclear modification factors for hadrons at forward and backward rapidities in deuteron-gold collisions at sqrt[s(NN)]=200 GeV. Phys Rev Lett (2005) 0.75
Onset of pi(0) suppression studied in Cu+Cu collisions at sqrt S NN=22.4, 62.4, and 200 GeV. Phys Rev Lett (2008) 0.75
Elliptic and hexadecapole flow of charged hadrons in Au+Au collisions at sq.rt(s(NN))=200 GeV. Phys Rev Lett (2010) 0.75
Particle-species dependent modification of jet-induced correlations in Au+Au collisions at sqrt[s_{NN}]=200 GeV. Phys Rev Lett (2008) 0.75
Saturation of azimuthal anisotropy in Au + Au collisions at (square root)s(NN) = 62-200 GeV. Phys Rev Lett (2005) 0.75
J/psi production and nuclear effects for d + Au and p + p collisions at square root of S(NN) = 200 GeV. Phys Rev Lett (2006) 0.75
Charged Kaon interferometric probes of space-time evolution in Au+Au collisions at sqrt[S(NN)]=200 GeV. Phys Rev Lett (2009) 0.75